Les médicaments à libération prolongée pour les enfants et les adolescents ayant un trouble de déficit de l’attention avec hyperactivité
Mark Feldman(University of Toronto), Stacey A Bélanger(Canadian Paediatric Society)
Cited by 1
Related Papers
Screen time and young children: Promoting health and development in a digital world
|Paediatrics & Child Health|2017|398
Evaluation of the child with global developmental delay and intellectual disability
|Paediatrics & Child Health|2018|163
ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity
|Paediatrics & Child Health|2018|130
Toxicity profile of interferon alfa-2b in children: A prospective evaluation
|The Journal of Pediatrics|1999|126
Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder
|Prostaglandins Leukotrienes and Essential Fatty Acids|2008|101